Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
August 19, 2008

ArunA Obtains Commercialization Rights to Univ. of Georgia's Human Mesenchymal Stem Cells

  • ArunA Biomedical gained a license that allows it to commercialize human mesenchymal cells (hMSC™) developed at the University of Georgia Research Foundation. These hMSCs are derived from human embryonic stem cells.

    ArunA reports that it will offer the academic and industrial research communities access to a highly uniform population of human mesenchymal cells grown as adherent monolayer cultures in multiple turn-key kit formats.

    “We are targeting an early first quarter 2009 launch of ArunA's first hMSC kit,”  says William Sharp, president and CEO.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.